POINT Biopharma Global Inc
PNT | $13.68 2.63% 0.15% 0
|
(0.0% 1d) (0.0% 1m) (54.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-11-13
Market Cap: $ 1,457,867,080
https://www.pointbiopharma.com
Sec Filling | Patents | 74952 employees
POINT Biopharma Global Inc. is a globally focused radiopharmaceutical company building a platform for the clinical development and commercialization of radioligands that fight cancer. POINT Biopharma Global Inc. is combining a portfolio of best-in-class radiopharmaceutical assets, a seasoned management team, expertise in radioisotopes such as Actinium-225 (Ac-225) and Lutetium-177 (Lu-177), and industry-leading manufacturing capabilities and supply chain to revolutionize theragnostic drug development and radioligand commercialization.
cancer
add to watch list Paper trade email alert is off
Press-releases
Lantheus Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-22 (Crawled : 12:00) - globenewswire.com
LNTH | $61.48 -0.41% -0.39% 11
|
Health Technology
|
| O: 11.09%
H: 4.11%
C: 3.25%
year financial results
Lantheus Reports Preliminary Fiscal Year 2023 Revenue
Published: 2024-01-09 (Crawled : 13:00) - globenewswire.com
LNTH | $61.48 -0.41% -0.39% 11
|
Health Technology
|
| O: 0.6%
H: 0.03%
C: -3.99%
year revenue
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect™
Published: 2024-01-04 (Crawled : 12:30) - prnewswire.com
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: 1.22%
H: 1.78%
C: -1.72%
Lilly to Participate in J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 15:00) - prnewswire.com
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: -0.43%
H: 2.12%
C: 2.03%
conference
Lilly Completes Acquisition of POINT Biopharma
Published: 2023-12-27 (Crawled : 13:30) - prnewswire.com
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: -0.03%
H: 2.31%
C: 1.93%
biopharma acquisition
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
Published: 2023-12-20 (Crawled : 13:00) - globenewswire.com
PPBT | $0.4343 5.39% 11.19% 280K
|
Manufacturing
|
| O: -5.11%
H: 3.97%
C: -4.28%
PNT | $13.68 2.63% 0.15% 0
|
|
| O: 0.12%
H: 0.0%
C: 0.0%
biotech purple
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Published: 2023-12-18 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -10.09%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: 1.61%
H: 1.14%
C: 0.57%
LNTH | $61.48 -0.41% -0.39% 11
|
Health Technology
|
| O: -19.87%
H: 5.04%
C: -8.75%
positive cancer biopharma topline trial results
Lilly Extends Tender Offer to Acquire POINT Biopharma to Dec. 15, 2023
Published: 2023-12-04 (Crawled : 14:30) - biospace.com/
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: -1.96%
H: 0.0%
C: 0.0%
biopharma acquire
Lilly Announces the Receipt of NRC Consent in Connection with its Proposed Acquisition of POINT Biopharma
Published: 2023-11-14 (Crawled : 22:00) - prnewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -1.7%
H: 2.11%
C: 0.98%
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: 0.44%
H: 0.0%
C: 0.0%
biopharma acquisition
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Published: 2023-11-13 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -0.95%
H: 0.0%
C: 0.0%
LLY | News | $750.77 0.54% 0.15% 8.3K
|
Health Technology
|
| O: -0.26%
H: 4.11%
C: 3.09%
business biopharma financial results
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001193805-23-001635 | 4 | 2023-12-20 | 2023-12-18 | Sell | S | 8974245 | 0 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 57% | 43% |
Top 10 Gainers
INVO | $1.82 139.47% 49.67% 1.4M
|
Health Technology
WISA 4 | $9.25 51.64% 34.27% 64M
|
Electronic Technology
HOLO | $2.24 -5.49% 27.74% 7.7M
|
SRFM 4 | $0.3859 -12.3% 23.84% 660K
|
n/a
CTM | $0.2201 -2.31% 22.67% 48K
|
n/a
VIAO | $0.262 0.77% 16.03% 14M
|
Electronic Technology
DXF | $0.2708 -5.71% 14.48% 190K
|
Finance
GRFX | $0.2159 -10.04% 12.55% 5.9K
|
n/a
BHIL | $0.1722 -3.8% 12.08% 290K
|
Agriculture, Forestry, Fishing ...
ANVS | $8.99 -10.81% 10.9% 270K
|
Health Technology
Last 48 Hours Insiders Buying
IZEA | $2.53 1.2% -2.4% 0
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.58% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.37 -1.41% -1.02% 0
|
Retail Trade
|
22:00
BRN P 10650 | $2.79 2.2% 0.0% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.53 -3.16% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10